Putnam Investments’s Integra LifeSciences IART Stock Holding History

Putnam Investments’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-23,100	Closed	-$1.28M	–	1120
2018 Q1	$1.28M	Sell	23,100 -1,141	-5%	-$59.8K	﹤0.01%	816
2017 Q4	$1.16M	Sell	24,241 -15,156	-38%	-$742K	﹤0.01%	871
2017 Q3	$1.99M	Buy	39,397 +13,507	+52%	+$694K	﹤0.01%	766
2017 Q2	$1.41M	Buy	25,890 +8,060	+45%	+$385K	﹤0.01%	852
2017 Q1	$751K	Sell	17,830 -4,306	-19%	-$184K	﹤0.01%	1052
2016 Q4	$950K	Buy	22,136 +358	+2%	+$14.6K	﹤0.01%	1021
2016 Q3	$899K	Sell	21,778 -28,942	-57%	-$1.21M	﹤0.01%	1037
2016 Q2	$2.02M	Buy	+50,720	New	+$1.82M	﹤0.01%	923

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Putnam Investments's IART Position: Q2 2018 in Review

Putnam Investments sold out of Integra LifeSciences (IART) in Q2 2018, closing a stake of 23,100 shares — an estimated $1.28M sold.

Putnam Investments first reported a position in IART in Q2 2016 and held it in 8 quarters. The position peaked at $2.02M in Q2 2016. 257 funds tracked by Wall St. Rank hold IART as of Q2 2018.

Putnam Investments reported no remaining Integra LifeSciences position as of Q2 2018 after selling out during the quarter.
Putnam Investments sold 23,100 Integra LifeSciences shares in Q2 2018, an estimated $1.28M.
Putnam Investments first reported a position in Integra LifeSciences in Q2 2016 and held it in 8 quarters.
Putnam Investments's Integra LifeSciences position peaked at $2.02M in Q2 2016.
257 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2018.

Based on Putnam Investments's 13F filing for Q2 2018, filed 14 Aug 2018.